EmblemHealth sues AstraZeneca subsidiary for blocking competitors to rare blood disease drug

Crain's New York Business

Apr 18, 2025

Insurer EmblemHealth is leading a class-action lawsuit against a subsidiary of AstraZeneca, claiming that the company blocked competition for a pricey, rare blood disease medicatio…